Analysis of Neisseria lactamica antigens putatively implicated in acquisition of natural immunity to Neisseria meningitidis

FEMS Immunology and Medical Microbiology

Volumn 34, Issue 1, 2002, Pages 9-15

  Troncoso, G ^a   Sanchez S ^a   Criado, M T ^a   Ferreiros C M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Cross reactive antigen; Natural immunity; Neisseria meningitidis

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CROSS REACTING ANTIBODY; OUTER MEMBRANE PROTEIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONTROLLED STUDY; CROSS REACTION; EPIDEMIC MENINGITIS; HUMAN; IMMUNITY; MOLECULAR WEIGHT; MOUSE; MUCOSA; NEISSERIA; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CROSS REACTIONS; HUMANS; IMMUNITY, NATURAL; IMMUNIZATION; MENINGITIS, MENINGOCOCCAL; MICE; MICE, INBRED BALB C; MOLECULAR WEIGHT; NEISSERIA; NEISSERIA MENINGITIDIS; SPECIES SPECIFICITY;

EID: 0037031587     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(02)00326-7     Document Type: Article

References (40)

1. Borrow R., Longworth E., Gray S.J., Kaczmarski E.B. Prevalence of thio-acetylated serogroup C meningococci before the introduction of meningococcal serogroup C conjugate vaccines in the United Kingdom. FEMS Immunol. Med. Microbiol. 28:2000;189-191.
2. Daum, R.S. and Granoff, D.M. (1994) Lesson from the evaluation of immunogenicity. In: Development and Clinical Uses of Haemophilus B Conjugate Vaccines (Ellis, R.W. and Granoff, D.M., Eds.), pp. 291-312. Marcel Dekker, New York.
3. Fine J., Leinonen M., Makela P.H. Antigen similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet. 2:1983;355-357.
4. Hadi H.A., Wooldridge K.G., Robinson K., Ala'Aldeen D.A.A. Identification and characterization of APP: an immunogenic autotransporter protein of Neisseria meningitidis. Mol. Microbiol. 41:2001;611-623.
5. Zollinger W.D., Mandrell R.E., Altieri P., Berman S., Lowenthal J., Artenstein M.S. Safety and immunogenicity of Neisseria meningitidis type 2 protein vaccines in animals and humans. J. Infect. Dis. 137:1978;728-739.
6. Jennings H.J., Lugowski C., Ashton F.E. Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against B Neisseria meningitidis. Can. J. Biochem. 51:1984;1347-1354.
7. Milagres L.G., Gorla M.C.A., Sacchi C.T., Rodrigues M.M. Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine. Infect. Immun. 66:1998;4755-4761.
8. Cann K.J., Rogers T.R. Detection of antibodies to common antigens of pathogenic and commensal Neisseria species. J. Med. Microbiol. 30:1989;23-30.
9. Hoehn G.T., Clark V.L. Distribution of a protein antigenically related to the major anaerobically induced gonococcal outer membrane protein among other Neisseria species. Infect. Immun. 58:1990;3929-3933.
10. Ala'Aldeen D.A., Wall R.A., Borriello S.P. Immunogenicity and cross-reactivity of the 70-kDa iron-regulated protein of Neisseria meningitidis in man and animals. J. Med. Microbiol. 32:1990;275-281.
11. Cannon J.G., Back W.J., Nachakim I., Steward P. Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseria species but not to most non-pathogenic Neisseria species. Infect. Immun. 43:1984;994-999.
12. Robbins J.B., Schneerson R., Glode M.P., Vann W., Schiffer M.S., Liu T.-Y., Parke J.C., Huntley C. Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria. J. Allergy Clin. Immunol. 56:1975;141-151.
13. Martin D., Brodeur B.R., Hamel J., Couture F., de Alwis U., Lian Z., Martin S., Andrews D., Ellis R.W. Candidate Neisseria meningitidis NspA vaccine. J. Biotech. 83:2000;27-31.
14. Troncoso G., Sánchez S., Moreda M., Criado M.T., Ferreirós C.M. Antigenic cross-reactivity between outer membrane proteins of Neisseria meningitidis and commensal Neisseria species. FEMS Immunol. Med. Microbiol. 27:2000;103-109.
15. Griffiss, J.M. (1995) Mechanisms of host immunity. In: Meningococcal Disease (Cartwright, K., Ed.), pp. 35-70. John Wiley and Sons, New York.
16. Jansen C., Wiese A., Reubsaet L., Dekker N., de Cock H., Seydel H., Tommansen J. Biochemical and biophysical characterization of in vitro folded outer membrane porin PorA of Neisseria meningitidis. Biochim. Biophys. Acta. 1464:2000;284-298.
17. Wang J., Jarvis G.A., Achtman M., Rosenqvist E., Michaelsen T.E., Aase A., Griffis M.L. Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis. Infect. Immun. 68:2000;1871-1878.
18. Suakkonnen K., Leininen M., Abdillahi M., Poolman J.T. Comparative evaluation of potential components for serogroup B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine. 7:1999;325-328.
19. Roupp van der Voort E.M., Kuipers B., Brugghe H.F., Van Unen L.M., Timmermans H.A., Hoogerhout P., Poolman J. Epitope specificity of murine and human bactericidal antibodies against PorA P1.7, 16 induced with experimental meningococcal group B vaccines. FEMS Immunol. Med. Microbiol. 17:1997;139-148.
20. Minetti C.A.S.A., Blake M.S., Remeta D. Characterization of the structure, function and conformational stability of PorB class 3 protein of Neisseria meningitidis. J. Biol. Chem. 273:1998;25329-25338.
21. Pollard A.J., Frasch C. Development of natural immunity to Neisseria meningitidis. Vaccine. 19:2001;1327-1346.
22. Munkley A., Tinsley C.R., Vitji M., Heckels J.E. Blocking of bactericical killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein. Microb. Pathog. 11:1991;447-452.
23. Rosenqvist E., Musacchio A., Aase A., Høiby E.A., Namork E., Kolberg J., Wedege E., Delvig A., Dalseg R., Michaelsen T.E., Tommasen J. Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (RmpM) of Neisseria meningitidis. Infect. Immun. 67:1999;1267-1276.
24. Wiertz E.J.H.J., Delvig A., Donders E.M.L.M., Brugghe H.F., Van Unen L.M.A., Timmermans H.A.M., Achtman M., Hoogerhout P., Poolman J.T. T-cell responses to outer membrane proteins of Neisseria meningitidis comparative study of the Opa, Opc and PorA proteins. Infect. Immun. 64:1996;298-304.
25. Rosenqvist E., Høiby E.A., Wedege E., Kusecek B., Achtman M. The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies. J. Infect. Dis. 167:1993;1065-1073.
26. Gómez J.A., Criado M.T., Ferreirós C.M. Bactericidal activity of antibodies elicited against the Neisseria meningitidis 37-kDa ferric binding protein (FbpA) with different adjuvants. FEMS Immunol. Med. Microbiol. 20:1998;79-86.
27. Smith P.K., Krohn R.I., Hermason G.T., Mallia A.K., Gartner F.H., Provezano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Clenck D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
28. Brodeur B.R., Larose Y., Tsang P., Hamel J., Ashton F., Ryan A. Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody. Infect. Immun. 50:1985;510-516.
29. Fletcher J.J., Zak K., Virji M., Heckels J.E. Monoclonal antibodies to gonococcal outer membrane protein I: location of a conserved epitope on protein IB. J. Gen. Microbiol. 132:1986;1611-1620.
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature. 277:1970;680-685.
31. Neuhoff V., Stam R., Eibl H. Clear background and highly sensitive protein staining with Coomassie blue dyes in polyacrylamide gels: a systematic analysis. Electrophoresis. 6:1985;427-448.
32. Wood, J.N. (1984) Solid-phase screening of monoclonal antibodies. In: Methods in Molecular Microbiology I. Proteins (Walker, J.M., Ed.), pp. 279-286. Humana Press, Clifton, NJ.
33. Lee C., Levin A., Branton D. Copper staining: a five minute protein stain for sodium dodecyl sulfate-polyacrylamide gels. Anal. Biochem. 166:1987;308-312.
34. Milagres L.G., Brandileone M.C., Sacchi C.T., Vieira V.S.D., Zanella R.C., Frasch C.E. Antibody studies in mice of outer membrane antigens for use in an improved meningococcal B and C vaccine. FEMS Immunol. Med. Microbiol. 13:1996;9-17.
35. Peeters C.C.A.M., Rümke H.C., Sundermann L.C., Rouppe van der Voort E.M., Meulenbelt J., Schuller M., Kuipers A.J., van der Ley P., Poolman J.T. Phase I clinical trial with a hexavalent PorA containing meningococcal outer vesicle vaccine. Vaccine. 14:1996;1009-1015.
36. Guttormsen H.K., Wetzler L.M., Næss A. Humoral immune response to class 3 outer membrane protein during the course of meningococcal disease. Infect. Immun. 61:1993;4734-4742.
37. Claassen I., Meylis J., van der Ley P., Peeters C., Brons H., Robert J., Borsboom D., van der Ark A., van Straaten I., Roholl P., Kuipers B., Poolman J. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine. 14:1996;1001-1008.
38. Toleman M., Aho E., Virgi M. Expression of pathogen-like Opa adhesins in commensal Neisseria: genetic and functional analysis. Cell. Microbiol. 3:2001;33-44.
39. Jolley K.A., Appleby L., Wright J.C., Christodoulides M., Heckels J.E. Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: Influence of sequence variation and levels of expression on the bactericidal immune response against meningococci. Infect. Immun. 69:2001;3809-3816.
40. Nazábal C., Carmenate T., Cruz S., González S., Silva R., Musacchio A., Delgado M., Chinea G. Mapping of monoclonal antibodies specific to P64k: a common antigen of several isolates of Neisseria meningitidis. Can. J. Microbiol. 47:2001;158-164.